Cargando…

L1CAM High Expression Associates with Poor Prognosis in Glioma but Does Not Correlate with C11orf95-RELA Fusion

The latest WHO guideline of CNS tumor defined a RELA fusion-positive ependymoma type with extremely poor prognosis, and the expression of L1CAM was correlated well with the presence of RELA fusion. However, the L1CAM protein expression in large sample gliomas other than ependymoma, its relationship...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Jing, Xi, Shao-Yan, Wang, Fang, Liao, Hua-Dong, Yang, Yuan-Zhong, Hu, Wan-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251433/ https://www.ncbi.nlm.nih.gov/pubmed/32509846 http://dx.doi.org/10.1155/2020/1353284

Ejemplares similares

C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma
por: Parker, Matthew, et al.
Publicado: (2014)

EPEN-02. FUNCTION AND DEPENDENCY OF NF-KB ACTIVITY IN C11ORF95-RELA FUSION EPENDYMOMA
por: Stuckert, Austin, et al.
Publicado: (2021)

EPEN-09. SUPER ENHANCER GENES AS MOLECULAR TARGETS IN C11ORF95-RELA FUSION EPENDYMOMA
por: Bertrand, Kelsey, et al.
Publicado: (2021)

C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma
por: Zhu, Jacqueline Jufen, et al.
Publicado: (2020)

C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation
por: Ozawa, Tatsuya, et al.
Publicado: (2021)

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors
por: Fukuoka, Kohei, et al.
Publicado: (2018)

EPEN-14. GENERATION OF A C11orf95-RELA FUSION TARGETING ANTIBODY AS A DIAGNOSTIC TOOL FOR SUPRATENTORIAL EPENDYMOMA
por: Ruff, Lisa, et al.
Publicado: (2020)

EPEN-30. C11ORF95-RELA FUSION PROTEIN ENGAGES NOVEL GENOMIC LOCI TO DRIVE MURINE EPENDYMOMA GROWTH
por: Arabzade, Amir, et al.
Publicado: (2020)

EPEN-53. C11orf95-RELA REPROGRAMS 3D EPIGENOME IN SUPRATENTORIAL EPENDYMOMA
por: Zhu, Jacqueline Jufen, et al.
Publicado: (2020)

Publisher Correction to: C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation
por: Ozawa, Tatsuya, et al.
Publicado: (2021)

EPEN-41. C11orf95-RELA FUSION REGULATES ABERRANT GENE EXPRESSION THROUGH THE UNIQUE GENOMIC BINDING SITES FOR EPENDYMOMA FORMATION
por: Ozawa, Tatsuya, et al.
Publicado: (2020)

EPEN-01. C11ORF95-RELA DICTATES ONCOGENIC TRANSCRIPTIONAL PROGRAMS TO DRIVE AGGRESSIVE SUPRATENTORIAL EPENDYMOMA
por: Arabzade, Amir, et al.
Publicado: (2021)

A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB
por: Ozawa, Tatsuya, et al.
Publicado: (2018)

Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma
por: Tomomasa, Ran, et al.
Publicado: (2021)

EPEN-34. THE CRISPR-Cas9 SYSTEM-MEDIATED ENDOGENOUS GENE REARRANGEMENT INDUCED C11orf95-RELA FUSION IN VITRO AND IN VIVO THAT LED TO THE DEVELOPMENT OF EPENDYMOMA-LIKE TUMOR
por: Takadera, Mutsumi, et al.
Publicado: (2020)

KLF11 Expression Predicts Poor Prognosis in Glioma Patients
por: Xi, Zhuo, et al.
Publicado: (2021)

EPEN-03. ZFTA/C11ORF95 FUSIONS DRIVE SUPRATENTORIAL EPENDYMOMA VIA SHARED ONCOGENIC MECHANISMS
por: Zheng, Tuyu, et al.
Publicado: (2021)

EPEN-36. THE TREATMENT OUTCOME OF PAEDIATRIC SUPRATENTORIAL C11ORF95-RELA FUSED EPENDYMOMA: A COMBINED REPORT FROM E-HIT SERIES AND AUSTRALIAN NEW ZEALAND CHILDREN’S HAEMATOLOGY/ONCOLOGY GROUP
por: Ng, Chia Huan, et al.
Publicado: (2020)

EPEN-18. CROSS-SPECIES GENOMICS IDENTIFIES GLI2 AS AN ONCOGENE OF C11orf95 FUSION-POSITIVE SUPRATENTORIAL EPENDYMOMA
por: Zheng, Tuyu, et al.
Publicado: (2020)

Fusion of ZMYND8 and RELA Genes in Acute Erythroid Leukemia
por: Panagopoulos, Ioannis, et al.
Publicado: (2013)

Pure Cortical Ependymoma With RELA-Fusion Positive in a Young Adult
por: Lee, Sang-Woo, et al.
Publicado: (2021)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

EPEN-25. A novel spontaneous model of ZFTA-RELA fusion ependymoma
por: Bell, Sigourney, et al.
Publicado: (2022)

Low Frequency of ESRRA–C11orf20 Fusion Gene in Ovarian Carcinomas
por: Micci, Francesca, et al.
Publicado: (2014)

Aggressive Supratentorial Ependymoma, RELA Fusion-Positive with Extracranial Metastasis: A Case Report
por: Kim, Seong-Ik, et al.
Publicado: (2017)

LINC-29. IMPACT OF RELA FUSION ON OUTCOMES OF CHILDHOOD SUPRATENTORIAL EPENDYMOMAS (ST-EPEN)
por: Chinnaswamy, Girish, et al.
Publicado: (2020)

EPEN-01. ZFTA-RELA FUSION PROGRAMS CONVERGE ON YAP PATHWAY ACTIVATION IN EPENDYMOMA
por: Stuckert, Austin, et al.
Publicado: (2023)

Stapling proteins in the RELA complex inhibits TNFα-induced nuclear translocation of RELA
por: Kour, Smit, et al.
Publicado: (2021)

PTBP-dependent PSD-95 and CamKIIα alternative splicing in the lens
por: Frederikse, Peter, et al.
Publicado: (2014)

Rap2c as a Novel Biomarker for Predicting Poor Prognosis in Glioma
por: Wang, Xiucun, et al.
Publicado: (2020)

TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023)

ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma
por: Salzman, Julia, et al.
Publicado: (2011)

High expression of TXNDC11 indicated unfavorable prognosis of glioma
por: Peng, Peng, et al.
Publicado: (2021)

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
por: Cheang, Tuck-yun, et al.
Publicado: (2016)

Increased Gene Expression of C1orf74 Is Associated with Poor Prognosis in Cervical Cancer
por: Parida, Preetiparna, et al.
Publicado: (2023)

Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas
por: Yu, Shoukai
Publicado: (2022)

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
por: Ralhan, Ranju, et al.
Publicado: (2010)

MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer
por: Zhou, Ning, et al.
Publicado: (2015)

SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis
por: Park, Hyunjin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k73l3e79026acp9ev6106rfscg